Show notes
Gabe and Annie Rench are back for round two on the biggest trend in health and fitness right now: GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. A year after their first Ozempic episode blew up, they revisit the topic with fresh eyes — why so many people (maybe one in three women, by their guess) feel like they have no other option, what the British Medical Journal's newest research says about weight regain after stopping, and why "just eat less" is the most reductionist advice in modern medicine.
💦 IN THIS EPISODE:
What GLP-1/GIP agonist drugs (semaglutide, tirzepatide, and the…
